Sayit Mahmut Erdogan

Sayit Mahmut Erdogan serves as an Assistant Professor in the Department of Immunology and Microbiology at the University of Copenhagen, affiliated with the Centre for Medical Parasitology (CMP) and BIVAC. His research focuses on developing novel vaccine platforms against infectious diseases, with laboratory access at Blegdamsvej 3B, 2200 København N, and contactable via phone (+4535331653) or email (sayit.erdogan@sund.ku.dk).

His core research interests include:

• Vaccine design using modular capsid and virus-like particle platforms
• Neutralizing antibody induction against viral pathogens like SARS-CoV-2
• Bispecific immune engagers for malaria therapeutics
• Translational immunology bridging basic research and clinical applications
• Parasite-host immune interactions in infectious disease contexts

Analysis of his publication record reveals a strong emphasis on rapid-response vaccinology for emerging pathogens. The 2023 Lancet Microbe trial demonstrated the first-in-human application of a modular capsid platform for SARS-CoV-2, while the 2021 Nature Communications study showed how receptor-binding domain decoration enhances viral neutralization. His Cell Death & Disease work extended these principles to malaria, indicating cross-disease applicability of his platform technologies. Collectively, these publications exhibit a consistent focus on innovative antigen presentation systems for infectious disease prevention.

Dr. Erdogan operates within the Centre for Medical Parasitology (CMP) and BIVAC collaborative networks, engaging in multidisciplinary research that integrates structural biology, immunology, and clinical translation. His work has generated significant external attention, including coverage by 31 news outlets, 3 blog posts, 42 social media mentions, and 7 patent references across his publications.